First Of Its Kind Pharmacokinetics Study On Cannabinoids For Dogs
Cornell University’s College of Veterinary Medicine has just announced the findings of the first-ever pharmacokinetic clinical trial on the effects of cannabinoids for dogs
The participating dogs in the study were suffering from multi joint issues. To conduct the 8-month double blind, placebo controlled study, Cornell collaborated with ElleVet Sciences. ElleVet Sciences was founded in Portland in 2017, and is in the business of creating soft-chew supplements for dogs made from proprietary hemp oil blends. The primary goal of the Cornell-ElleVet study was to understand how dogs metabolized ElleVet Mobility soft chews, which are hemp-based supplements also containing glucosamine and chondroitin, two natural compounds that may improve mobility in dogs. Glucosamine and chondroitin are already being widely used by humans.
Read More About the CBD + CBDA Studies Conducted by ElleVet Sciences
Copy and paste link to view full article: